72 related articles for article (PubMed ID: 27351098)
1. The Impact of Underweight Status on the Prognosis of Ovarian Cancer Patients: A Meta-Analysis.
Pergialiotis V; Doumouchtsis SK; Perrea D; Vlachos GD
Nutr Cancer; 2016; 68(6):918-25. PubMed ID: 27351098
[TBL] [Abstract][Full Text] [Related]
2. The relationship among obesity, nutritional status, and mortality in the critically ill.
Robinson MK; Mogensen KM; Casey JD; McKane CK; Moromizato T; Rawn JD; Christopher KB
Crit Care Med; 2015 Jan; 43(1):87-100. PubMed ID: 25289931
[TBL] [Abstract][Full Text] [Related]
3. Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer.
Kim SI; Kim HS; Kim TH; Suh DH; Kim K; No JH; Chung HH; Kim YB; Song YS
J Immunol Res; 2014; 2014():349546. PubMed ID: 25050383
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Preoperative Underweight Status on Postoperative Complication and Survival Outcome of Gastric Cancer Patients: A Systematic Review and Meta-analysis.
Zhao B; Zhang J; Zhang J; Zou S; Luo R; Xu H; Huang B
Nutr Cancer; 2018; 70(8):1254-1263. PubMed ID: 30686045
[TBL] [Abstract][Full Text] [Related]
5. Extremes of body mass index and postoperative complications after esophagectomy.
Wightman SC; Posner MC; Patti MG; Ganai S; Watson S; Prachand V; Ferguson MK
Dis Esophagus; 2017 May; 30(5):1-6. PubMed ID: 28375438
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy for ovarian cancer survivors: systematic review and meta-analysis.
Pergialiotis V; Pitsouni E; Prodromidou A; Frountzas M; Perrea DN; Vlachos GD
Menopause; 2016 Mar; 23(3):335-42. PubMed ID: 26308232
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
Dis Colon Rectum; 2015 Nov; 58(11):1048-57. PubMed ID: 26445177
[TBL] [Abstract][Full Text] [Related]
8. Association between underweight and low lymphocyte count as an indicator of malnutrition in Japanese women.
Nishida T; Sakakibara H
J Womens Health (Larchmt); 2010 Jul; 19(7):1377-83. PubMed ID: 20509783
[TBL] [Abstract][Full Text] [Related]
9. Impact of being underweight on the long-term outcomes of patients with gastric cancer.
Migita K; Takayama T; Matsumoto S; Wakatsuki K; Tanaka T; Ito M; Kunishige T; Nakade H; Nakajima Y
Gastric Cancer; 2016 Jul; 19(3):735-43. PubMed ID: 26298184
[TBL] [Abstract][Full Text] [Related]
10. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
Liu C
Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
[TBL] [Abstract][Full Text] [Related]
11. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
12. Malnutrition as a predictor of poor postoperative outcomes in gynecologic cancer patients.
Kathiresan AS; Brookfield KF; Schuman SI; Lucci JA
Arch Gynecol Obstet; 2011 Aug; 284(2):445-51. PubMed ID: 20803205
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis.
Doleman B; Mills KT; Lim S; Zelhart MD; Gagliardi G
Tech Coloproctol; 2016 Aug; 20(8):517-35. PubMed ID: 27343117
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early-stage epithelial ovarian cancer.
Skírnisdóttir I; Sorbe B
Int J Gynecol Cancer; 2008; 18(2):345-51. PubMed ID: 17587318
[TBL] [Abstract][Full Text] [Related]
15. Underweight and malnutrition in home care: A multicenter study.
Lahmann NA; Tannen A; Suhr R
Clin Nutr; 2016 Oct; 35(5):1140-6. PubMed ID: 26460221
[TBL] [Abstract][Full Text] [Related]
16. Gender and age disparities in adult undernutrition in northern Uganda: high-risk groups not targeted by food aid programmes.
Schramm S; Kaducu FO; Smedemark SA; Ovuga E; Sodemann M
Trop Med Int Health; 2016 Jun; 21(6):807-17. PubMed ID: 27102720
[TBL] [Abstract][Full Text] [Related]
17. Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer.
Cascales-Campos PA; Gil J; Gil E; Feliciangeli E; González-Gil A; Parrilla JJ; Parrilla P
Ann Surg Oncol; 2014 Jul; 21(7):2383-9. PubMed ID: 24599409
[TBL] [Abstract][Full Text] [Related]
18. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Body Mass Index on Postoperative Morbidity After Orthopaedic Surgery in Children With Cerebral Palsy.
Minhas SV; Chow I; Otsuka NY
J Pediatr Orthop; 2016; 36(5):505-10. PubMed ID: 25929775
[TBL] [Abstract][Full Text] [Related]
20. Prechemotherapy Hemoglobin Levels as a Predictive Factor of Ovarian Cancer Survival: A Systematic Review and Meta-Analysis.
Pergialiotis V; Daskalakis G; Thomakos N; Bellos I; Haidopoulos D; Loutradis D; Rodolakis A
Am J Clin Oncol; 2019 Sep; 42(9):725-731. PubMed ID: 31361606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
